Related Experiment Video

Updated: Aug 15, 2026

Diagonal Method to Measure Synergy Among Any Number of Drugs
12:08

Diagonal Method to Measure Synergy Among Any Number of Drugs

Published on: June 21, 2018

Antimicrobial synergism in the therapy of experimental cerebral nocardiosis

M E Gombert1, L duBouchet, T M Aulicino

  • 1Department of Medicine, State University of New York, Health Science Center, Brooklyn 11203.

The Journal of Antimicrobial Chemotherapy
|July 1, 1989
PubMed

Insights

The study found that combining imipenem with either cefotaxime or trimethoprim/sulphamethoxazole (TMP/SMP) effectively reduced bacterial counts in a mouse model of cerebral nocardiosis. TMP/SMP alone showed no efficacy.

Area of Science:

  • Infectious Diseases
  • Microbiology
  • Pharmacology

Background:

  • Cerebral nocardiosis is a serious infection requiring effective antimicrobial therapy.
  • Optimizing treatment strategies for central nervous system infections is crucial.
  • Evaluating synergistic antimicrobial combinations can improve treatment outcomes.

Purpose of the Study:

  • To assess the efficacy of imipenem-cefotaxime and imipenem-trimethoprim/sulphamethoxazole (TMP/SMP) combinations against cerebral nocardiosis in a mouse model.
  • To compare the synergistic effects of these combinations against monotherapy with each agent.
  • To identify the most effective antimicrobial strategy for reducing bacterial load in brain tissue.

Main Methods:

  • A mouse model of cerebral nocardiosis was established.
  • Animals received treatment with imipenem-cefotaxime, imipenem-TMP/SMP, cefotaxime alone, TMP/SMP alone, imipenem alone, or saline control for 72 hours.
  • Bacterial colony counts per gram of brain tissue were quantified post-therapy.

Main Results:

  • Both imipenem-cefotaxime and imipenem-TMP/SMP combinations significantly reduced bacterial colony counts.
  • These combinations were statistically superior to cefotaxime and TMP/SMP monotherapy.
  • Imipenem monotherapy showed comparable efficacy to the combinations, while TMP/SMP monotherapy was ineffective and inferior to all other treatments.

Conclusions:

  • Synergistic combinations of imipenem with cefotaxime or TMP/SMP demonstrate significant efficacy in treating experimental cerebral nocardiosis.
  • Imipenem-based combinations offer a promising therapeutic approach for this severe infection.
  • Trimethoprim/sulphamethoxazole alone is not an effective treatment for cerebral nocardiosis in this model.

More Related Videos

Antimicrobial Synergy Testing by the Inkjet Printer-assisted Automated Checkerboard Array and the Manual Time-kill Method12:03

Antimicrobial Synergy Testing by the Inkjet Printer-assisted Automated Checkerboard Array and the Manual Time-kill Method

Published on: April 18, 2019

High Throughput Co-culture Assays for the Investigation of Microbial Interactions07:00

High Throughput Co-culture Assays for the Investigation of Microbial Interactions

Published on: October 15, 2019

Related Concept Videos

Antibiotic Selection00:57

Antibiotic Selection

Overview
Combined Effects of Drugs: Antagonism01:30

Combined Effects of Drugs: Antagonism

The combined effects of drugs can result in various interactions, of which an important type is antagonism. Antagonism is a mechanism where one drug inhibits or counteracts the effects of another drug. Antagonism can occur through various means, including receptor binding, allosteric modulation, functional interaction, chemical reactions, and pharmacokinetic processes.
The most common type is receptor antagonism, where one drug acts as an antagonist to block the effects of another drug by...
Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Antimicrobial Effectiveness01:28

Antimicrobial Effectiveness

The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...
Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...